We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cloudcall Group Plc | LSE:CALL | London | Ordinary Share | GB00B4XS5145 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 79.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/10/2019 11:33 | From their website: "Long Path Partners is a privately-owned investment firm that manages two concentrated equity Partnerships. The Firm employs an ‘ownershipR | the millipede | |
28/10/2019 07:22 | Long Path Partners, LP invests 7pc | ali47fish | |
10/10/2019 20:10 | 2014 the pompous ar*e hole Cleaver told me face to face they were fully funded to cash flow break even 5 years later still no guarantee they are fully funded and still not cash flow break even. Lifestyle Company paid for by shareholders. | pj 1 | |
10/10/2019 18:04 | They are hardly promoting the PI offer - why on earth would I want to buy shares and immediately lose money on it? | davr0s | |
01/10/2019 10:41 | Cloudcall has always had two options. The first, favoured by some posters on here, has been to prioritise break-even; the second, to go for growth and worry about profitability later. In my mind, this company has done enough to prove the business model works and I think the better long term plan is to go for growth, if it can be funded at reasonable rates. The board clearly agree as confirmed by the placing announcement. There is nothing underhand about this and I think it reflects a genuine attempt to build a large profitable business for the long term. As for the small offer for current shareholders, the company is in a bit of a fix because they would be pilloried by us if we had been excluded; at the same time, judging by comments here, most of us are a bit sceptical (preferring the break even option above) and in any case many of us have averages well under the current price so it is not obviously in our interests to buy more stock at this price. So I wonder if the open offer will be especially well supported, but either way that does not mean the board have got things wrong IMO. | the millipede | |
30/9/2019 19:30 | If they're EIS-qualifying and you can use the tax advantages, it might be a reasonable deal. Certainly worth thinking about. | supernumerary | |
30/9/2019 19:29 | Probably made it so small because it was embarrassing to see how many people actually put their hand in their pockets. Cleaver is a scumbag. He was supposed to have enough cash to take him to breakeven about 5 years ago. Thieving shizz. | horndean eagle | |
30/9/2019 18:49 | 1 for 38 lol - surprised they bothered widening the participation if you can call it that | davr0s | |
30/9/2019 17:38 | RNS: open offer is 1 for every 53 that you hold at 100p per share. you can apply for more | davemac3 | |
30/9/2019 10:47 | A 'Premium' I'm sure. But to what share price I am unsure. They must hold the world record along with SEE for the number of Placings? | pj 1 | |
30/9/2019 10:42 | I'm out... at a loss. But good luck to holders. In the current climate, and having fallen under the £ threshold, the profits keep on evading the business model... But have read P Scott's report of Stocko, and he seems to think it might be taken over at a premium. | brucie5 | |
30/9/2019 08:13 | V positive update - revenue to accelerate into H2 and US especially strong. I'll be picking some up in the open offer if I can get my hands on some. | jimbojet17 | |
29/7/2019 18:08 | Looks likely to continue recovery, which means buying has not stopped post results. 1.20 will confirm this. | brucie5 | |
24/7/2019 15:50 | Apparently not. | brucie5 | |
23/7/2019 19:55 | big buy at the end. onwards and upwards. | mfhmfh | |
22/7/2019 10:37 | We seem to be creeping up again. I wouldn't be surprised to see resumption of trend here, which seems to be the pattern after results pullback. Peeps maybe buying into the 30% growth story? | brucie5 | |
17/7/2019 20:47 | Every dog has its day Monty.... Maybe, just maybe this will come, and be multiples of the current price. Worth a flutter rather than an investment IMO... (Biased as per earlier posts). | deltrotter | |
17/7/2019 16:23 | Smithson, thanks for pointing that out, he wrote a detailed analysis as you say in the comments... I have copied his Summary below: My opinion - each investor will form their own views on this. i understand the frustration of bears on this stock. But for me, the potential upside is sufficiently large, that I don't really mind the bumps in the road - it comes with the territory, and doesn't undermine the upside case very much at all, in my view. Maybe I take a longer term view than others? If growth had stalled, or even gone negative, then I'd unceremoniously ditch this share as a failure. However, the 30%+ organic growth is genuinely exciting. The product works well (I know, as I've tried it), and good momentum is clearly there, with customer growth. It looks cheap to me. | montyville2 | |
17/7/2019 15:49 | I quite like his articles. Yes someone told me he lost a small fortune on Medisys a few years back. He does in my opinion try to give an honest analysis as he sees it. | 1fox1 | |
17/7/2019 15:02 | fox and monty he did comment, he put it in the comments section. I am not sure if it can be directly copied as the SCVR is pay for now. He was basically pleased with the update and surprised that the price fell yesterday. He listened to the webinar and was overall impressed, said that 30% organic growth was still great and that the previous broker targets were set too high. Noted the bull and bear points and again some frustration with break even being pushed back. He seems to believe that eventually the company will be sold on, he recently bought more and at a higher price than yesterday. I think blindly following PS can be quite dangerous but he has a lot of respect from people. I also hold these myself and do agree with his views. He does great analysis but sometimes just seems to buy junk. | jpsmithson | |
17/7/2019 14:59 | Fox, this is what he said on 4 June: "My opinion - this company has disappointed in the past, but has I believe reached a tipping point where things are starting to work. This was one of my small cap ideas at the recent Mello London conference - see page 8 of my presentation slides here. After a few false starts in recent years, I think this share could re-rate nicely if sales momentum continues. I see good upside here. Strongly growing SaaS businesses tend to be highly rated, especially in the US. £26m market cap at circa 100p per share, looks cheap to me." I think many would agree that the 'sales momentum' is indeed continuing, so I see no reason why Paul would take a different view given the latest update. | montyville2 | |
17/7/2019 14:06 | Okay Thanks anyway | 1fox1 | |
17/7/2019 13:52 | Fox, he has not commented on the SCVP as yet, his colleague Graham Neary was author that day and it wasnt covered | montyville2 | |
17/7/2019 10:24 | Anyone got a copy of what Paul Scott had to say? Cheers | 1fox1 | |
17/7/2019 07:25 | I do agree with that PJ1 - they will want to dump this on to another company at some point to exit.... | deltrotter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions